Literature DB >> 6494022

Quantification of the permeability of the blood-CSF barrier to alpha-MSH in the rat.

J F Wilson, S Anderson, G Snook, K D Llewellyn.   

Abstract

The ability of alpha-MSH to cross the blood-CSF barrier of the rat was assessed by measurement of the rate of appearance of immunoreactive alpha-MSH in a cerebrospinal fluid (CSF) perfusate following intravenous injection of peptide. Comparisons were made with the rate of appearance of a simultaneously administered dose of 14C-inulin which is poorly permeable at the blood-CSF barrier. Concentrations of drugs measured in plasma were fitted to two-compartment pharmacokinetic models, and those measured in the CSF perfusate to one-compartment open systems receiving an input from the plasma compartment. The rate constant for entry of alpha-MSH into CSF was 0.00087 min-1, which was not significantly different from that for inulin of 0.00055 min-1. As alpha-MSH penetrated into CSF at a rate comparable to inulin, it was concluded that the limited entry of peptide was by aqueous diffusion along with other water-soluble macromolecules.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6494022     DOI: 10.1016/0196-9781(84)90006-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

Review 1.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

Review 2.  Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

3.  The role of mPer2 clock gene in glucocorticoid and feeding rhythms.

Authors:  Shutong Yang; Aiyi Liu; Adam Weidenhammer; Robert C Cooksey; Donald McClain; Myung K Kim; Greti Aguilera; E Dale Abel; Jay H Chung
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

4.  Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive alpha-melanotropin.

Authors:  J F Wilson
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.